Overview
From accurate staging to the state-of-the-art treatments, Seattle Cancer Care Alliance (SCCA) patients receive the best care possible from some of the world’s leading doctors. Patients receive a comprehensive evaluation and consensus recommendation on diagnosis and personalized treatment plan from a panel of liver tumor specialists including surgical oncologists, medical oncologists, transplant hepatologists, surgeons, diagnostic and interventional radiologists, and pathologists. We treat a broad array of primary and second tumors:
| Primary Tumors | Secondary Tumors | |
|
Hepatocellular Carcinoma Cholangiocarcinoma:
Adenomas Focal Nodular Hyperplasia Hemangioma Cysts:
|
Colorectal Breast Neuroendocrine/Carcinoid Uterine/Ovarian/Cervical Gastrointestinal Stromal Tumor Lung Melanoma Pancreas Sarcoma |
The Liver Tumor Clinic team offers the full spectrum and latest in diagnosis and treatment:
- Surgical resection: laparoscopic, open, or daVinci robotic
- Radiofrequency ablation: percutaneous, laparoscopic, open, or thoracoscopic
- "NanoKnife" Irreversible Electroporation: percutaneous, laparoscopic, or open
- Chemoembolization
- Radioembolization
- Transplantation
- Systemic therapy
- Radiation therapy
New Treatments in Clinical Studies
SCCA was formed, in part, to bring promising new treatments to patients faster. For you, this means more treatment options at SCCA than might be found elsewhere, including participation in one of many ongoing clinical research studies conducted at SCCA and its founding organizations, Fred Hutchinson Cancer Research Center and UW Medicine.